2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Other neoplasm
1
Conditions
Precancerous Conditions
1
Interventions
Cyclophosphamide
13
Biopsy
13
fludarabine phosphate
9
Whole-Body Irradiation
9
Surveys and Questionnaires
9
Peripheral Blood Stem Cell Transplantation
9
Busulfan
9
Polymerase Chain Reaction
7
Mycophenolic Acid
7
Early Intervention, Educational
7
Tacrolimus
6
Gene Expression Profiling
6
Educational Status
6
Colposcopy
6
Carboplatin
6
fludarabine
5
Paclitaxel
5
Microarray Analysis
5
Methotrexate
5
Methods
5
Melphalan
5
Immunohistochemistry
5
Epoetin Alfa
5
Decitabine
5
Cyclosporine
5
Cisplatin
5
Celecoxib
5
Antilymphocyte Serum
5
Aminolevulinic Acid
5
Sulindac
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
artemisinin
×
Other neoplasm
×
Clear all
NCT03100045
2021-11-03
ART-AIN
Johns Hopkins University
Phase 1
Completed
18 enrolled